跳至主要内容
临床试验/IRCT20180724040576N1
IRCT20180724040576N1招募中3 期

Comparison of propranolol plus cinarizine and propranolol plus placebo in control of migraine headaches in children attending Imam Reza clinic in Shiraz.

Shiraz University of Medical Sciences0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 14 years(—)
性别
All

入选标准

  • Every child with a diagnosis of migraine (according to international headache society)
  • There must be at least 4 episodes of migraine attacks per month.
  • The age range of 6 to 14 years.
  • A migraine headache with or without aura.
  • The patient has not used any drug for preventing migraine headaches during last month
  • Parents agreement and sign informed written consent form.

排除标准

  • The patient affected by other forms of migraine headache (variant migraine).
  • The patient has focal neurologic signs or radiologic findings in brain imaging.
  • There is a serious comorbidity.
  • There are other systemic diseases.
  • Inability to participate in the study.
  • Use of drugs for preventing attacks during last month
  • A contraindication to use of cinnarizine or propranolol (such as asthma or heart block).

研究者

相似试验